Global Percutaneous Coronary Intervention Devices Market Size, Market Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts, 2018 To 2026

  • ID: 4564648
  • Report
  • Region: Global
  • Acute Market Reports
1 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Getinge AB
  • Johnson & Johnson
  • Medtronic plc
  • MORE
Percutaneous Coronary Intervention Devices Market - Growth, Future Prospects and Competitive Analysis, 2018-2026, the global percutaneous coronary intervention devices market was valued at US$ 5.98 Bn in 2017, and is expected to reach US$ 8.70 Bn by 2026, expanding at a CAGR of 4.3% from 2018 to 2026.

Market Insights
Global percutaneous coronary intervention devices market is valued at US$ 5.98 Bn for the year 2017 and is mainly driven by increase in global burden of heart diseases, diabetes and coronary artery disease. Percutaneous coronary intervention is a non-surgical technique to prevent narrowing of the coronary arteries by removing the plaque using PTCA balloon catheters and placement of coronary stents. According to the American Heart Association, an estimated 15.5 million individuals older than 20 years of age had coronary artery disease in the year 2015 and this number is expected to further grow in the future. Other important factor contributing to the growth in number of percutaneous coronary intervention procedures include reduced risk of complications and infections compared to conventional treatment methods. However, lack of skilled professionals to perform the procedures hinders the growth of the global percutaneous coronary intervention devices market.

Based on device types, the global percutaneous coronary intervention devices market is segmented into coronary stents, PTCA catheters, and coronary guidewires. These devices are used in the treatment of coronary artery disease during PCI procedures. Coronary stents segment is expected to grow at substantial pace in the forecast period due to introduction of the new products in the market.

Based on the end-users, the global percutaneous coronary intervention devices market is segmented into hospitals, ambulatory surgical centers (ASCs), and catheterization labs. In terms of market value, hospitals segment is expected to dominate the global percutaneous coronary intervention devices market for the year 2017 due to greater availability of the skilled professionals required to perform the procedure, and greater footfall of target patients in hospitals. However, as the healthcare infrastructure is expanding in both developed and developing economies, and greater preference for specialized treatment locations is observed in both patients and care-givers, the dominance of hospitals is expected to be challenged by catheterization labs.

Based on the geographical segmentation, North America is expected to dominate the global percutaneous coronary intervention devices market for the year 2017 due to greater awareness of the general population about management of heart diseases, and better reimbursement scenario. However, proliferation of medical tourism and the flourishing healthcare market in Asia Pacific will make the region progress at a faster growth rate than the global benchmark. Market players have varied product portfolio from offering only stents to sporting the entire portfolio for PCI. Major players in the global percutaneous coronary intervention devices market include Abbott Laboratories, Inc., B. Braun Melsungen AG, Biosensors International Group, Biotronik SE & Co. KG, Boston Scientific Corporation, Getinge AB, Johnson & Johnson, Medtronic plc, St. Jude Medical LLC, and Terumo Corporation.
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biotronik SE & Co. KG
  • Getinge AB
  • Johnson & Johnson
  • Medtronic plc
  • MORE
Chapter 1. Preface
1.1. Report Scope and Description
1.2. Research Methodology
1.2.1. Phase I-Secondary Research
1.2.2. Phase II-Primary Research
1.2.3. Phase III-Expert Panel Review
1.2.4. Assumptions
1.2.5. Approach Adopted

Chapter 2. Executive Summary
2.1. Global Percutaneous Coronary Intervention Devices Market Portraiture
2.1.1. Global Percutaneous Coronary Intervention Devices Market, by Device Type, 2017 (US$ Bn)
2.1.2. Global Percutaneous Coronary Intervention Devices Market, by End-user, 2017 (US$ Bn)
2.1.3. Global Percutaneous Coronary Intervention Devices Market, by Geography, 2017 (US$ Bn)

Chapter 3. Percutaneous Coronary Intervention Devices Market: Market Dynamics and Outlook
3.1. Market Definition and Overview
3.2. Drivers
3.3. Challenges
3.4. Opportunities
3.5. Attractive Investment Proposition, by Geography
3.6. Value Chain Analysis
3.7. Porter’s Five Forces Model
3.8. Competitive Landscape
3.8.1. Competitive Landscape, by Key Players, 2017

Chapter 4. Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
4.1. Overview
4.1.1. Attractive Investment Proposition, by Device Type, 2017
4.2. Coronary Stents
4.3. PTCA Catheters
4.4. Coronary Guidewires

Chapter 5. Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
5.1. Overview
5.1.1. Comparative Analysis: Global Percutaneous Coronary Intervention Devices Market, by End-user, 2017 Vs 2026 (Value %)
5.2. Hospitals
5.3. Ambulatory Surgical Centers (ASCs)
5.4. Catheterization Labs

Chapter 6. Percutaneous Coronary Intervention Devices Market, by Geography, 2016 – 2026 (US$ Bn)
6.1. Overview
6.2. North America Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.2.1. North America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.2.2. North America Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.2.3. North America Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
6.2.3.1. U.S.
6.2.3.2. Canada
6.3. Europe Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.3.1. Europe Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.3.2. Europe Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.3.3. Europe Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
6.3.3.1. U.K.
6.3.3.2. Germany
6.3.3.3. Rest of Europe
6.4. Asia Pacific Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.4.1. Asia Pacific Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.4.2. Asia Pacific Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.4.3. Asia Pacific Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
6.4.3.1. China
6.4.3.2. Japan
6.4.3.3. Rest of APAC
6.5. Latin America Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.5.1. Latin America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.5.2. Latin America Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.5.3. Latin America Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
6.5.3.1. Brazil
6.5.3.2. Mexico
6.5.3.3. Rest of Latin America
6.6. Middle East & Africa (MEA) Percutaneous Coronary Intervention Devices Market Analysis, 2016 – 2026 (US$ Bn)
6.6.1. MEA Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
6.6.2. MEA Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
6.6.3. MEA Percutaneous Coronary Intervention Devices Market, by Region, 2016 – 2026 (US$ Bn)
6.6.3.1. GCC
6.6.3.2. Rest of MEA

Chapter 7. Company Profiles
7.1. Abbott Laboratories
7.1.1. Business Description
7.1.2. Financial Information (Subject to data availability)
7.1.3. Application Portfolio
7.1.4. Key Developments
7.2. B. Braun Melsungen AG
7.3. Biosensors International Group
7.4. Biotronik SE & Co. KG
7.5. Boston Scientific Corporation
7.6. Getinge AB
7.7. Johnson & Johnson
7.8. Medtronic plc
7.9. St. Jude Medical.
7.10. Terumo Corporation

List of Figures
FIG. 1 Percutaneous Coronary Intervention: Market Segmentation
FIG. 2 Global Percutaneous Coronary Intervention Devices Market, by Device Type, 2017 (US$ Bn)
FIG. 3 Global Percutaneous Coronary Intervention Devices Market, by End-user, 2017 (US$ Bn)
FIG. 4 Global Percutaneous Coronary Intervention Devices Market, by Geography, 2017 (Value %)
FIG. 5 Attractive Investment Proposition, by Geography
FIG. 6 Market Competition Landscape, by Key Players, 2017
FIG. 7 Global Coronary Stents Market, 2016 – 2026 (US$ Bn)
FIG. 8 Global PTCA Catheters Market, 2016 – 2026 (US$ Bn)
FIG. 9 Global Coronary Guidewires Market, 2016 – 2026 (US$ Bn)
FIG. 10 Global PCI Market in Hospitals, 2016 – 2026 (US$ Bn)
FIG. 11 Global PCI Market in Ambulatory Surgical Centers, 2016 – 2026 (US$ Bn)
FIG. 12 Global PCI Market in Catheterization Labs, 2016 – 2026 (US$ Bn)
FIG. 13 U.S. Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 14 Canada Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 15 U.K. Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 16 Germany Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 17 Rest of Europe Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 18 Japan Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 19 China Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 20 Rest of Asia Pacific Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 21 Brazil Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 22 Mexico Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 23 Rest of Latin America Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 24 GCC Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)
FIG. 25 Rest of Middle East and Africa Percutaneous Coronary Intervention Devices Market, 2016 – 2026 (US$ Bn)

List of Tables
TABLE 1 Global Percutaneous Coronary Intervention Devices Market Portraiture
TABLE 2 Global Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 3 Global Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 4 Global Percutaneous Coronary Intervention Devices Market, by Geography, 2016 – 2026 (US$ Bn)
TABLE 5 North America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 6 North America Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 7 North America Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 8 Europe Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 9 Europe Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 10 Europe Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 11 Asia Pacific Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 12 Asia Pacific Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 13 Asia Pacific Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 14 Latin America Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 15 Latin America Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 16 Latin America Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 17 Middle East and Africa Percutaneous Coronary Intervention Devices Market, by Device Type, 2016 – 2026 (US$ Bn)
TABLE 18 Middle East and Africa Percutaneous Coronary Intervention Devices Market, by End-user, 2016 – 2026 (US$ Bn)
TABLE 19 Middle East and Africa Percutaneous Coronary Intervention Devices Market, by Country, 2016 – 2026 (US$ Bn)
TABLE 20 Abbott Laboratories: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 21 B. Braun Melsungen AG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 22 Biosensors International Group: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 23 Biotronik SE & Co. KG: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 24 Boston Scientific Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 25 Getinge AB: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 26 Johnson & Johnson: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 27 Medtronic plc: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 28 St. Jude Medical: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
TABLE 29 Terumo Corporation: Company Snapshot (Business Description; Financial Information; Product Portfolio; News Coverage)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Abbott Laboratories
  • B. Braun Melsungen AG
  • Biosensors International Group
  • Biotronik SE & Co. KG
  • Boston Scientific Corporation
  • Getinge AB
  • Johnson & Johnson
  • Medtronic plc
  • St. Jude Medical.
  • Terumo Corporation
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll